Risk factors ID'd for poor cutaneous cell CA outcomes

May 17, 2013
Risk factors ID'd for poor cutaneous cell CA outcomes
The risks of metastasis and death associated with cutaneous squamous cell carcinoma are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond fat, poor differentiation, and location, according to a study published in the May issue of JAMA Dermatology.

(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond fat, poor differentiation, and location, according to a study published in the May issue of JAMA Dermatology.

To identify risk factors associated with poor outcomes in primary CSCC, Chrysalyne D. Schmults, M.D., from Brigham and Women's Hospital in Boston, and colleagues retrospectively analyzed CSCC outcomes for 985 patients with 1,832 tumors.

The researchers found that over a median follow-up of 50 months, local occurred in 4.6 percent of patients, 3.7 percent developed nodal metastases, and 2.1 percent died of CSCC. Independent predictors for nodal and disease-specific death included a tumor diameter of at least 2 cm (subhazard ratios, 7.0 and 15.9, respectively), poor differentiation (6.1 and 6.7), invasion beyond fat (9.3 and 13.0), and ear or temple location (3.8 and 5.9), according to multivariate competing risk analyses. Disease-specific death was associated with perineural invasion (subhazard ratio, 3.6) and anogenital location, but few cases were anogenital. Poor differentiation (subhazard ratio, 1.3) and invasion beyond fat (1.7) correlated with overall death.

"Cutaneous carries a low but significant risk of metastasis and death," write the authors. "Accurate risk estimation of outcomes from population-based data and clinical trials proving the utility of disease-staging modalities and adjuvant therapy is needed."

Explore further: Prognostic factors identified in mucoepidermoid carcinoma

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Prognostic factors identified in mucoepidermoid carcinoma

August 10, 2012
(HealthDay) -- Diagnosis of low- or intermediate-grade tumors is associated with significantly better overall survival and disease-free survival in patients with mucoepidermoid carcinoma (MEC) of the salivary glands, while ...

New study points to the aggressive potential of small kidney tumours, advocates treatment

March 18, 2013
Small kidney tumours have an agressive potential and should be treated, according to a the results of a large multicentre study presented at the 28th Annual EAU Congress in Milan.

Low-risk bladder cancer rarely progresses to muscle invasion

March 6, 2013
(HealthDay)—Low-risk bladder cancer rarely progresses to muscle invasion but is associated with an increased risk of disease-specific mortality compared with matched populations, according to research published in the March ...

Prospective study finds many children with retinoblastoma can safely forego adjuvant chemotherapy

March 4, 2013
New results from a prospective clinical trial conducted in France show that children with low-risk retinoblastoma do not need postoperative (adjuvant) chemotherapy to prevent disease recurrence or metastasis; the results ...

Association between genetic mutation and risk of death for patients with thyroid cancer

April 9, 2013
Presence of the genetic mutation BRAF V600E was significantly associated with increased cancer-related death among patients with papillary thyroid cancer (PTC); however, because overall mortality in PTC is low and the association ...

Diabetes affects improvements after lumbar spine surgery

April 2, 2013
(HealthDay) —Patients with diabetes who have longstanding diabetes, poor glycemic control, and use insulin had suboptimal improvements in clinical outcomes after lumbar spine surgery, according to research published March ...

Recommended for you

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.